Abstract:In the current study, Eupatorin was efficiently encapsulated in mPEG-b-PLGA coated iron oxide nanoparticles.The nanoparticles bypass the limitations and provide a sustained release of eupatorin into DU-145 and LNcaP human prostate cancer cell lines.Eupatorin loaded Fe3O4@mPEG-b-PLGA nanoparticles can be more effective in inhibiting cancer cell growth as compared to free form.Many studies have so far confirmed the efficiency of phytochemicals in the treatment of prostate cancer. Eupatorin, a flavonoid with a wide range of phytomedical activities, suppresses proliferation of and induces apoptosis in multiple cancer cell lines. However, low solubility, poor bioavailability, and rapid degradation limit its efficacy. The aim of our study was to evaluate whether the use of mPEG-b-PLGA coated iron oxide nanoparticles as a carrier could enhance the therapeutic efficacy of eupatorin in DU-145 and LNcaP human prostate cancer cell lines. Nanoparticles were prepared by the co-precipitation method and were fully characterized for morphology, surface charge, particle size, drug loading, encapsulation efficiency and in vitro drug-release profile. The inhibitory effect of nanoparticles on cell viability was evaluated by MTT test. Apoptosis was then determined by Hoechest staining, cell cycle analysis, NO production, annexin/PI assay, and western blotting. The results indicated that eupatorin was successfully entrapped in Fe3O4@mPEG-b-PLGA nanoparticles with an efficacy of 90.99 ± 2.1%. The nanoparticle's size was around 58.5 ± 4 nm with a negative surface charge (-34.16 ± 1.3 mV). In vitro release investigation showed a 30% initial burst release of eupatorin in 24h followed by sustained release over 200h. The MTT assay indicated that eupatorin loaded Fe3O4@mPEG-b-PLGA nanoparticles exhibited a significant decrease in the growth rate of DU-145 and LNcaP cells and their IC50 concentrations were 100 μM and 75 μM respectively. Next, apoptosis was confirmed by nuclear condensation, enhancement of cell population in the sub-G1 phase and increasing NO level. Annexin/PI analysis demonstrated that eupatorin loaded Fe3O4@mPEG-b-PLGA nanoparticles could increase apoptosis and decrease necrosis frequency. Finally, Western blot analysis confirmed these results and showed that Bax/Bcl2 ratio and the cleaved-caspase3 level were up-regulated by the designing nanoparticles. Encapsulation of eupatorin in Fe3O4@mPEG-b-PLGA nanoparticles increased its anticancer effects in prostate cancer cell lines as compared to free eupatorin. Based on these results, this formulation can provide a sustained eupatorin-delivery system for cancer treatment with the drug remaining active at a significantly lower dose making it a suitable candidate for pharmacological uses.Schematic representation of eupatorin loaded Fe3O4@mPEG-b-PLGA nanoparticles synthesis, characterization and in vitro apoptosis detection test.Download : Download high-res image (324KB)Download : Download full-size image

The natural flavone eupatorin induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells

Eupatorin-Induced Cell Death in Human Leukemia Cells Is Dependent on Caspases and Activates the Mitogen-Activated Protein Kinase Pathway

Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis

Euphornin Reduces Proliferation of Human Cervical Adenocarcinoma HeLa Cells Through Induction of Apoptosis and G2/M Cell Cycle Arrest

Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway.

Eupatilin Inhibits the Proliferation of Human Esophageal Cancer TE1 Cells by Targeting the Akt‑GSK3β and MAPK/ERK Signaling Cascades.

Eupalinolide O, a Novel Sesquiterpene Lactone from Eupatorium Lindleyanum DC., Induces Cell Cycle Arrest and Apoptosis in Human MDA-MB-468 Breast Cancer Cells.

Eupafolin enhances TRAIL-mediated apoptosis through cathepsin S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim up-regulation in renal carcinoma Caki cells

RETRACTED ARTICLE: Eupafolin induces apoptosis and autophagy of breast cancer cells through PI3K/AKT, MAPKs and NF-κB signaling pathways

Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines

Euphorane C, an unusual C17-norabietane diterpenoid from Euphorbia dracunculoides induces cell cycle arrest and apoptosis in human leukemia K562 cells

Inhibitory Effect of Serum Containing Eupolyphaga on the Proliferation of Human Hepatoma Cell Line HepG-2

Mechanism of action of cytotoxic compounds from the seeds of Euphorbia lathyris

Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex.

Eupatilin Impacts on the Progression of Colon Cancer by Mitochondria Dysfunction and Oxidative Stress

Eupatorin Suppressed Tumor Progression and Enhanced Immunity in a 4T1 Murine Breast Cancer Model

Effect of euphorbia factor L1 on oxidative stress, apoptosis, and autophagy in human gastric epithelial cells

Daphnoretin-induced Apoptosis in HeLa Cells: a Possible Mitochondria-Dependent Pathway

Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway

Cucurbitacin E Induces G2/M Phase Arrest through STAT3/p53/p21 Signaling and Provokes Apoptosis via Fas/CD95 and Mitochondria-Dependent Pathways in Human Bladder Cancer T24 Cells

An unusual indole-diterpenoid with C-17 norcassane skeleton from Euphorbia fischeriana induces HEL cell cycle arrest and apoptosis